Previous close | 91.35 |
Open | 91.35 |
Bid | 75.00 |
Ask | 85.00 |
Strike | 910.00 |
Expiry date | 2025-12-19 |
Day's range | 91.35 - 91.35 |
Contract range | N/A |
Volume | |
Open interest | 10 |
REGN maintains momentum as Eylea HD gains traction and Dupixent maintains momentum, even as lead drug Eylea faces challenges.
We recently made a list of Morgan Stanley’s Best Overweight & Quality Stocks: Top 25 Stocks. In this piece, we will look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) ranks on the list of the top overweight and quality stocks. The close of September has cemented the paradigm shift on Wall Street. With the Federal Reserve’s […]
We recently compiled a list of the 10 Buzzing AI Health Stocks. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other buzzing AI health stocks. The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are […]